Oraya Therapeutics, of Newark, CA, has received CE approval for its IRay stereotactic radiotherapy system. The IRay system is a low-energy, stereotactic radiosurgical device for the office-based, noninvasive treatment of wet age-related macular degeneration (AMD). IRay delivers a precise dose of radiation to the macula using a robotic positioning s (Read more...)
Uncategorized